Dominant nodules within Hashimoto thyroiditis (HT) may present with unique morphological
features that overlap with but are not diagnostic of papillary thyroid carcinoma (PTC) …

Point mutations in BRAF are genetic hallmarks of papillary thyroid carcinoma (PTC). In this
retrospective study, we examined thyroid aspirates and corresponding paraffin-embedded …

The relationship between Hashimoto's thyroiditis (HT) and follicular cell-derived thy roid
cancer remains unclear. Recently, 2 studies reported a 95% prevalence of RET/PTC …

Papillary carcinoma is the most common type of thyroid malignancy. It has been recently
shown that these tumors commonly have one of three genetic alterations: BRAF point …

Neoplastic transformation is a multistep process that results in a continuous spectrum from
the normal (physiological) state to a fully established neoplasm. The gold standard for …

Background Concomitant papillary thyroid cancer (PTC) and H ashimoto's thyroiditis (HT) is
a frequent occurrence. Whether these two conditions are linked and whether PTC with …

Background: It has been reported that patients with papillary thyroid carcinoma (PTC) have a
high incidence of background Hashimoto thyroiditis (HT); however, the linkage of HT to PTC …

Objective RAS mutations are the most common mutations in thyroid nodules with
indeterminate cytology by fine‐needle aspiration cytology (FNAC), and are mutually …

Objective: To evaluate the significance of BRAF V600E and Ras mutations, and RET
rearrangements in papillary thyroid cancer (PTC) in the South central region of China …

Background Activating mutations of the oncogene BRAF or rearrangements of the tyrosine
kinase receptor RET are observed in up to 80% of papillary thyroid carcinomas (PTCs). The …